On February 28, 2023, the company received $1,700,000 in its first tranche. The transaction included participation from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd. and Huons Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33,900 KRW | -3.97% | -2.45% | -11.72% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
65,200 KRW | -0.61% | -4.26% | 414M | ||
33,900 KRW | -3.97% | -2.45% | 294M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.72% | 294M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- A243070 Stock
- News Huons Co., Ltd.
- GenEdit Inc. amended terms of the transaction